Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: an Australian case-control-family study.

Cust AE, Goumas C, Vuong K, Davies JR, Barrett JH, Holland EA, Schmid H, Agha-Hamilton C, Armstrong BK, Kefford RF, Aitken JF, Giles GG, Bishop D, Newton-Bishop JA, Hopper JL, Mann GJ, Jenkins MA.

BMC Cancer. 2013 Sep 4;13:406. doi: 10.1186/1471-2407-13-406.

2.

MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.

Landi MT, Kanetsky PA, Tsang S, Gold B, Munroe D, Rebbeck T, Swoyer J, Ter-Minassian M, Hedayati M, Grossman L, Goldstein AM, Calista D, Pfeiffer RM.

J Natl Cancer Inst. 2005 Jul 6;97(13):998-1007. Erratum in: J Natl Cancer Inst. 2005 Sep 21;97(18):1385.

PMID:
15998953
3.

MC1R genotypes and risk of melanoma before age 40 years: a population-based case-control-family study.

Cust AE, Goumas C, Holland EA, Agha-Hamilton C, Aitken JF, Armstrong BK, Giles GG, Kefford RF, Schmid H, Hopper JL, Mann GJ, Jenkins MA.

Int J Cancer. 2012 Aug 1;131(3):E269-81. doi: 10.1002/ijc.27357. Epub 2012 Jan 30.

4.

Development of a melanoma risk prediction model incorporating MC1R genotype and indoor tanning exposure: impact of mole phenotype on model performance.

Penn LA, Qian M, Zhang E, Ng E, Shao Y, Berwick M, Lazovich D, Polsky D.

PLoS One. 2014 Jul 8;9(7):e101507. doi: 10.1371/journal.pone.0101507. eCollection 2014.

5.

Indoor tanning and the MC1R genotype: risk prediction for basal cell carcinoma risk in young people.

Molinaro AM, Ferrucci LM, Cartmel B, Loftfield E, Leffell DJ, Bale AE, Mayne ST.

Am J Epidemiol. 2015 Jun 1;181(11):908-16. doi: 10.1093/aje/kwu356. Epub 2015 Apr 8.

6.

Development and External Validation of a Melanoma Risk Prediction Model Based on Self-assessed Risk Factors.

Vuong K, Armstrong BK, Weiderpass E, Lund E, Adami HO, Veierod MB, Barrett JH, Davies JR, Bishop DT, Whiteman DC, Olsen CM, Hopper JL, Mann GJ, Cust AE, McGeechan K; Australian Melanoma Family Study Investigators.

JAMA Dermatol. 2016 Aug 1;152(8):889-96. doi: 10.1001/jamadermatol.2016.0939.

PMID:
27276088
7.

Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.

Fargnoli MC, Altobelli E, Keller G, Chimenti S, Höfler H, Peris K.

Melanoma Res. 2006 Apr;16(2):175-82.

PMID:
16567973
8.

Does MC1R genotype convey information about melanoma risk beyond risk phenotypes?

Kanetsky PA, Panossian S, Elder DE, Guerry D, Ming ME, Schuchter L, Rebbeck TR.

Cancer. 2010 May 15;116(10):2416-28. doi: 10.1002/cncr.24994.

9.

Risk factors for keratinocyte skin cancer in patients diagnosed with melanoma, a large retrospective study.

Espinosa P, Pfeiffer RM, García-Casado Z, Requena C, Landi MT, Kumar R, Nagore E.

Eur J Cancer. 2016 Jan;53:115-24. doi: 10.1016/j.ejca.2015.10.058. Epub 2015 Dec 17.

PMID:
26702765
10.

Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype?

Dwyer T, Stankovich JM, Blizzard L, FitzGerald LM, Dickinson JL, Reilly A, Williamson J, Ashbolt R, Berwick M, Sale MM.

Am J Epidemiol. 2004 May 1;159(9):826-33.

PMID:
15105175
11.

Family history of skin cancer is associated with early-onset basal cell carcinoma independent of MC1R genotype.

Berlin NL, Cartmel B, Leffell DJ, Bale AE, Mayne ST, Ferrucci LM.

Cancer Epidemiol. 2015 Dec;39(6):1078-83. doi: 10.1016/j.canep.2015.09.005. Epub 2015 Sep 14.

12.

Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.

Goldstein AM, Chaudru V, Ghiorzo P, Badenas C, Malvehy J, Pastorino L, Laud K, Hulley B, Avril MF, Puig-Butille JA, Miniere A, Marti R, Chompret A, Cuellar F, Kolm I, Mila M, Tucker MA, Demenais F, Bianchi-Scarra G, Puig S, de-Paillerets BB.

Int J Cancer. 2007 Aug 15;121(4):825-31.

13.

Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma.

Vernali S, Waxweiler WT, Dillon PM, Kanetsky PA, Orlow I, Luo L, Busam KJ, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Dwyer T, Cust AE, Ollila DW, Begg CB, Berwick M, Thomas NE; GEM Study Group.

JAMA Dermatol. 2017 Oct 1;153(10):1026-1031. doi: 10.1001/jamadermatol.2017.2444.

PMID:
28746718
14.

Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.

Demenais F, Mohamdi H, Chaudru V, Goldstein AM, Newton Bishop JA, Bishop DT, Kanetsky PA, Hayward NK, Gillanders E, Elder DE, Avril MF, Azizi E, van Belle P, Bergman W, Bianchi-Scarrà G, Bressac-de Paillerets B, Calista D, Carrera C, Hansson J, Harland M, Hogg D, Höiom V, Holland EA, Ingvar C, Landi MT, Lang JM, Mackie RM, Mann GJ, Ming ME, Njauw CJ, Olsson H, Palmer J, Pastorino L, Puig S, Randerson-Moor J, Stark M, Tsao H, Tucker MA, van der Velden P, Yang XR, Gruis N; Melanoma Genetics Consortium.

J Natl Cancer Inst. 2010 Oct 20;102(20):1568-83. doi: 10.1093/jnci/djq363. Epub 2010 Sep 28.

15.

Melanocortin 1 receptor variants and skin cancer risk.

Han J, Kraft P, Colditz GA, Wong J, Hunter DJ.

Int J Cancer. 2006 Oct 15;119(8):1976-84.

16.

Sporadic melanoma in South-Eastern Italy: the impact of melanocortin 1 receptor (MC1R) polymorphism analysis in low-risk people and report of three novel variants.

Guida S, Bartolomeo N, Zanna PT, Grieco C, Maida I, De Summa S, Tommasi S, Guida M, Azzariti A, Foti C, Filotico R, Guida G.

Arch Dermatol Res. 2015 Aug;307(6):495-503. doi: 10.1007/s00403-015-1552-4. Epub 2015 Mar 4.

PMID:
25736238
17.

Host phenotype characteristics and MC1R in relation to early-onset basal cell carcinoma.

Ferrucci LM, Cartmel B, Molinaro AM, Gordon PB, Leffell DJ, Bale AE, Mayne ST.

J Invest Dermatol. 2012 Apr;132(4):1272-9. doi: 10.1038/jid.2011.402. Epub 2011 Dec 8.

18.

The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population.

Brudnik U, Branicki W, Wojas-Pelc A, Kanas P.

Exp Dermatol. 2009 Feb;18(2):167-74. doi: 10.1111/j.1600-0625.2008.00760.x. Epub 2008 Jul 7.

PMID:
18637131
19.

Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population.

Stratigos AJ, Dimisianos G, Nikolaou V, Poulou M, Sypsa V, Stefanaki I, Papadopoulos O, Polydorou D, Plaka M, Christofidou E, Gogas H, Tsoutsos D, Kastana O, Antoniou C, Hatzakis A, Kanavakis E, Katsambas AD.

J Invest Dermatol. 2006 Aug;126(8):1842-9. Epub 2006 Apr 6.

20.

Inherited variation at MC1R and histological characteristics of primary melanoma.

Taylor NJ, Busam KJ, From L, Groben PA, Anton-Culver H, Cust AE, Begg CB, Dwyer T, Gallagher RP, Gruber SB, Orlow I, Rosso S, Thomas NE, Zanetti R, Rebbeck TR, Berwick M, Kanetsky PA.

PLoS One. 2015 Mar 19;10(3):e0119920. doi: 10.1371/journal.pone.0119920. eCollection 2015.

Supplemental Content

Support Center